Hai-bo Zhu
State Key Laboratory For Bioactive Substances And Functions Of Natural Medicines, Beijing Key Laboratory Of New Drug Mechanisms And Pharmacological Evaluation Study, Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Higenamine as a Potential Pharmacologic Stress Agent in the Detection of Coronary Artery Disease.
Journal: Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
Published: November 02, 2022
Cordycepin alleviated metabolic inflammation in Western diet-fed mice by targeting intestinal barrier integrity and intestinal flora.
Journal: Pharmacological research
Published: February 22, 2022
Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
Journal: Journal of advanced research
Published: January 23, 2022
IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway.
IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway.
Journal: Acta pharmacologica Sinica
Published: January 13, 2022
NFAT activating protein with ITAM motif 1 (NFAM1) is upregulated on circulating monocytes in coronary artery disease and potentially correlated with monocyte chemotaxis.
Journal: Atherosclerosis
Published: February 13, 2020
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease.
Journal: Clinical epigenetics
Published: November 16, 2019
Butyrate Improves the Metabolic Disorder and Gut Microbiome Dysbiosis in Mice Induced by a High-Fat Diet.
Journal: Frontiers in pharmacology
Published: June 07, 2019
IMM-H007, a novel small molecule inhibitor for atherosclerosis, represses endothelium inflammation by regulating the activity of NF-κB and JNK/AP1 signaling.
Journal: Toxicology and applied pharmacology
Published: April 25, 2019
A novel AMPK activator improves hepatic lipid metabolism and leukocyte trafficking in experimental hepatic steatosis.
Journal: Journal of pharmacological sciences
Published: February 15, 2019
Comparative analysis of stimulation and binding characteristics of adenosine analogs to AMP-activated protein kinase.
Journal: Journal of Asian natural products research
Published: September 07, 2018
A potential strategy for treating atherosclerosis: improving endothelial function via AMP-activated protein kinase.
Journal: Science China. Life sciences
Published: January 11, 2018
The regulation effect of AMPK in immune related diseases.
Journal: Science China. Life sciences
Published: July 14, 2017
Last Updated: 09/26/2026